Extrapulmonary Neuroendocrine Carcinomas: Current Management and Future Perspectives
Journal of Clinical Medicine · 15.12.2023 · 12 (24) · 7715
DOI: 10.3390/jcm12247715 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 15.12.2023. Verfasst von Sara Stumpo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum-University of Bologna, Via Zamboni 33, 40126 Bologna, Italy. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 172 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Neuroendocrine carcinomas (NECs) are poorly differentiated and highly aggressive epithelial neuroendocrine neoplasms. The most common primary site is the lung, but they may arise in every organ. Approximately 37% of extrapulmonary NECs (EP-NECs) occur in the gastroenteropancreatic (GEP) tract, followed by the genitourinary (GU) system and gynecological tract. As a result of their rarity, there is scant evidence to guide treatment recommendations, and a multidisciplinary approach is essential for the management of such patients. Platinum-based chemotherapy currently represents the standard of care for EP-NECs of any site, mirroring the management of small-cell lung cancer (SCLC), but further approaches are still under investigation. Indeed, ongoing trials evaluating targeted therapies, immune checkpoint inhibitors (ICIs), and radionuclide therapy could provide potentially breakthrough therapeutic options. Given the relative dearth of evidence-based literature on these orphan diseases, the aim of this review is to provide an overview of the pathology and current treatment options, as well as to shed light on the most pressing unmet needs in the field.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum-University of Bologna, Via Zamboni 33, 40126 Bologna, Italy.
- Medical Oncology, AO S. Croce e Carle, 12100 Cuneo, Italy.
- Medical Oncology Unit, Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari, 70124 Bari, Italy.
- Oncology Unit, Ospedale IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy.
- Division of Medical Oncology, Department of Precision Medicine, University of Campania "Luigi Vanvitelli", 80131 Naples, Italy.
- Sarcomas and Rare Tumors Unit, Istituto Nazionale Tumori, IRCCS-Fondazione "G. Pascale", 80131 Naples, Italy.
ORCID-Profile: Elena Parlagreco, Luigi Pio Guerrera, Ina Valeria Zurlo, Davide Campana, Mauro Cives, Anna La Salvia, Giuseppe Lamberti
Zitieren
APA
Stumpo, S., Formelli, M. G., Persano, I., Parlagreco, E., Lauricella, E., Rodriquenz, M. G., Guerrera, L. P., Zurlo, I. V., Campana, D., Brizzi, M. P., Cives, M., La Salvia, A., & Lamberti, G. (2023). Extrapulmonary Neuroendocrine Carcinomas: Current Management and Future Perspectives. Journal of Clinical Medicine, 12(24), 7715. https://doi.org/10.3390/jcm12247715
Vancouver
Stumpo S, Formelli MG, Persano I, Parlagreco E, Lauricella E, Rodriquenz MG, et al. Extrapulmonary Neuroendocrine Carcinomas: Current Management and Future Perspectives. Journal of Clinical Medicine. 2023;12(24):7715. doi:10.3390/jcm12247715
BibTeX
@article{Stumpo2023,
author = {Stumpo, Sara and Formelli, Maria Giovanna and Persano, Irene and Parlagreco, Elena and Lauricella, Eleonora and Rodriquenz, Maria Grazia and Guerrera, Luigi Pio and Zurlo, Ina Valeria and Campana, Davide and Brizzi, Maria Pia and Cives, Mauro and La Salvia, Anna and Lamberti, Giuseppe},
title = {Extrapulmonary Neuroendocrine Carcinomas: Current Management and Future Perspectives},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {24},
pages = {7715},
doi = {10.3390/jcm12247715}
}
EUVIMED